Procaine hydrochloride

Quick links

Choose a section

Quick links to important sections

Advertisements

Procaine hydrochloride

Selected form

Advertisements
Advertisements

Method of action: Anesthetic, Local Anesthetic

Treatment option:

Advertisements

Overview of Procaine hydrochloride

Property Description
Active ingredient Procaine hydrochloride; often combined with Benzylpenicillin
Form Sterile solution or injectable suspension
Pharmacological class Local Anesthetic (Ester-type); Sodium Channel Blocker
Common use Inducing localized numbness (analgesia); extending antibiotic action
Origin Synthetic organic compound

Procaine hydrochloride is a synthetic organic compound and a classic ester-type local anesthetic that functions by temporarily blocking nerve signals to prevent pain sensation in a specific area. It is categorized pharmacologically as a sodium channel blocker and is administered via the parenteral route, typically by injection, to achieve its primary purpose of localized pain relief, or analgesia.

Procaine belongs to the older ester class of anesthetics, historically known by the trade name Novocain. It stabilizes the nerve cell membrane, interrupting the transmission of electrical impulses to create temporary numbness. Procaine works by preventing the initiation and conduction of nerve impulses, acting as a neural blocker.


Procaine Penicillin: A Unique Combination and Form

Procaine Penicillin (or Procaine Benzylpenicillin) is not a simple mixture but an equimolecular salt where the anesthetic Procaine is chemically bound to the antibiotic Benzylpenicillin (Penicillin G). This combination product is typically prepared as a sterile injectable suspension.

The resulting poorly soluble salt form prevents the rapid absorption of the antibiotic into the bloodstream. This formulation is particularly valued in settings where sustained therapeutic action is preferred over frequent dosing.


General Purpose: Analgesia and Sustained Action

In this combination, the primary purpose of the Procaine component is to provide localized numbness to mitigate the discomfort and sharp pain that often accompany the intramuscular injection of the antibiotic. This is its key differentiating factor in the injectable penicillin class.

Overall, the drug’s general benefit is to ensure sustained therapeutic action of the antibiotic component. A typical scenario involves the use of Procaine Penicillin to maintain effective antibiotic levels over several days, simplifying treatment regimens.

Regulatory References

  1. Procaine benzylpenicillin on the WHO EML
Advertisements

What side effects are possible with Procaine hydrochloride?

Possible side effects and safety information

Official regulatory documents classify the potential adverse effects of Procaine hydrochloride, particularly in its combination form (Procaine Penicillin G), across several physiological systems and frequency categories.

System-Organ Classes and Adverse Reactions

Side effects are grouped in regulatory labeling by the affected body system. Reactions documented in the Nervous System include a progression from excitation (restlessness, anxiety, tremors) to depression (drowsiness, respiratory arrest, convulsions). Effects on the Cardiovascular System may include myocardial depression, arrhythmias, heart block, and cardiac arrest. Allergic reactions, documented under the Immune System, range from common manifestations like urticaria to serious, occasionally fatal, Anaphylactic Reactions. Immediate Psychiatric Reactions, such as confusion and hallucinations, have also been reported.

Serious and Time-Related Safety Patterns

The most serious documented safety concerns include the risk of Local Anesthetic Systemic Toxicity (LAST), leading to systemic failure, and life-threatening hypersensitivity reactions. Furthermore, certain adverse effects associated with the combined formulation may have a delayed onset. Pseudomembranous Colitis (severe diarrhea) may occur up to two months or more after the antibiotic component is discontinued. Signs of Methemoglobinemia (abnormal blood coloration) may also be delayed by several hours after exposure.

Safety Considerations for Specific Populations

Safety notes specify constraints for specific patient groups. Infants and individuals with G6PD deficiency have an increased risk of developing Methemoglobinemia. Use is officially contraindicated in individuals with known hypersensitivity to any penicillin or procaine, or in those with the genetic disorder Pseudocholinesterase Deficiency.

Advertisements

Overdose and Emergency Response

Procaine hydrochloride Overdose and when to seek help

Overdose of Procaine hydrochloride is characterized as Local Anesthetic Systemic Toxicity (LAST), which results from high plasma concentrations, often due to overdosage or unintended intravascular administration. This toxicity profile severely affects the Central Nervous System (CNS) and the Cardiovascular System (CVS).

Documented Overdose Manifestations

Initial CNS symptoms may include confusion, restlessness, tremors, and twitching, which can progress rapidly to convulsions and eventual respiratory arrest. Cardiovascular effects involve depression of cardiac conduction, manifesting as hypotension, bradycardia, arrhythmias, and potentially leading to cardiovascular collapse and cardiac arrest.

When Immediate Medical Help is Required

It is mandated that patients or caregivers seek emergency medical attention immediately if an overdose is suspected or if serious signs such as severe CNS effects, breathing difficulty, or chest symptoms are experienced. Management of this dose-related toxicity requires the immediate availability of oxygen, resuscitative drugs, and cardiopulmonary equipment.

Supportive Management and Monitoring

Supportive measures focus on maintaining circulation and respiration and controlling convulsions. Continuous monitoring of cardiovascular and respiratory vital signs and the patient's state of consciousness is required. Additionally, official labeling states that reduced doses are necessary for acutely ill, elderly, or debilitated patients due to increased risk of toxicity.

Advertisements

Therapeutic Uses of Procaine hydrochloride

What Procaine Hydrochloride Treats: Main Uses and Benefits

Procaine hydrochloride is generally used to address symptoms related to physical discomfort by providing temporary numbness in the application area. This application is relevant in clinical settings that involve acute symptom patterns, such as minor surgical interventions or dental procedures. It may help make the process tolerable by easing the perception of sharp pain, which contributes to improved patient comfort during these interventions.


In its combined form (Procaine Penicillin G), the medication is applied across domains where additional symptomatic support is needed to treat conditions characterized by periods of heightened symptoms due to susceptible bacteria. The combination is relevant for easing symptoms associated with specific infections including syphilis, pneumonia, scarlet fever, and certain skin and soft tissue infections. This sustained therapeutic approach generally assists with easing the overall symptom load. A distinct supportive benefit is managing the symptoms related to localized discomfort associated with deep intramuscular injections.

“The primary goal is to provide supportive relief during symptomatic periods, helping patients cope more steadily with acute or difficult manifestations.”


Quick Fact: Supportive Role in Acute Pain and Systemic Strain
Procaine assists with managing two distinct symptom domains: localized acute pain (in procedural contexts) and the systemic symptom load of specific bacterial infections.

Regulatory References

  1. NIH StatPearls overview of Procaine uses
Advertisements

Eligibility and Restrictions for Use

Population Eligibility and Contraindications

The eligibility for Procaine hydrochloride is strictly defined by regulatory documents based on patient status, metabolic capacity, and hypersensitivity risk. These rules govern who may use the medicine and who must not.

Absolute Contraindications (Must Not Use):

  • Individuals with known hypersensitivity to procaine or any drug of the ester-type local anesthetic class.
  • Patients with known hypersensitivity to penicillins (for the combination form).
  • Use is prohibited in patients with Pseudocholinesterase deficiency, a condition impairing drug metabolism.
  • The drug is strictly contraindicated for Intravenous (IV), Subcutaneous (SC), or Intrathecal (IT) administration.

Conditional Use and Restrictions:

  • Elderly or acutely ill patients are eligible but require use with caution and may receive reduced doses.
  • Patients with impaired renal or hepatic function are eligible only under conditional use, often requiring careful dose consideration.
  • Pregnancy: Safe use concerning fetal development has not been established, and it is only used if the benefit outweighs the potential risk.
  • Lactation: Use is generally acceptable for nursing mothers, though official caution is noted.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Procaine hydrochloride identifies distinct interaction patterns based on the anesthetic agent, its metabolite, and the co-formulated antibiotic (Penicillin G).


Formal Contraindicated Combinations

Combination Official Rationale
Sulfonamide Antibiotics The Procaine metabolite, para-aminobenzoic acid (PABA), formally inhibits the action of sulfonamide drugs.
Ergot-type Oxytocic Drugs Prohibited if the Procaine formulation contains a vasoconstrictor (e.g., epinephrine), due to the risk of severe persistent hypertension.

Documented Pharmacodynamic and Exposure Interactions

Co-administration with other Local Anesthetics results in toxic effects that are formally documented as additive. The co-use of Procaine with Methemoglobinemia-Associated Agents (such as nitrates or certain antibiotics) increases the risk of developing methemoglobinemia.

For Procaine formulations containing a vasoconstrictor, co-administration with substances like Monoamine Oxidase Inhibitors (MAOI), Tricyclic Antidepressants (TCA), and Nonselective Beta-Adrenergic Antagonists requires extreme caution due to the risk of severe blood pressure or cardiac rhythm disturbances.

Exposure-Modifying Agents

Probenecid is documented to block the renal tubular secretion of the Penicillin G component, which increases the serum concentrations and prolongs its elimination. Additionally, the penicillin component may increase the serum concentrations of Methotrexate and may affect the anticoagulant action of Vitamin K Antagonists.

Advertisements

Mechanism of Action

Neural Impulse Blockade via Sodium Channels

Procaine hydrochloride primarily functions as a local anesthetic by acting as a non-competitive inhibitor of voltage-gated sodium channels (Na^+ channels) on peripheral nerve fibers. The ionized molecule physically blocks the channel pore from the cell's interior, preventing the rapid sodium ion influx required for the rising phase of the action potential. This mechanism interrupts the electrical signal transmission within the nociceptive pathway, resulting in a predictable, temporary sensory blockade at the injection site.


Sustained Release Mechanism and Synergy

In combination products, Procaine’s mechanism involves a secondary chemical step: forming a poorly soluble equimolecular salt with the co-administered drug (e.g., Benzylpenicillin). This salt acts as a local drug depot, ensuring a slow, controlled dissolution and release, which prolongs the systemic presence of the second component. Procaine’s own immediate Na^+ channel blockade simultaneously mitigates the painful sensation associated with the intramuscular administration.


⏱️ Metabolic Constraints on Mechanism Duration

The intrinsic duration of the sensory blockade is constrained by Procaine's ester chemical structure, which is rapidly broken down through hydrolysis by the enzyme plasma pseudocholinesterase in the bloodstream. This rapid enzymatic degradation swiftly inactivates the active molecule, which is the direct biological reason the resulting sensory blockade is short-lived, typically limiting its duration.

Advertisements

Dosage and Administration Information

Procaine hydrochloride administration is structured around its two main applications: as a local anesthetic solution and as a component in the antibiotic Procaine Penicillin G combination. As a local anesthetic, the medicine is administered via local infiltration, peripheral nerve block, or neuraxial anesthesia. Dosing is standardized, with the maximum single administration dose restricted to 1000 mg, although procedural limits are often lower.

Procaine HCl solutions are commonly prepared with a vasoconstrictor such as epinephrine, which serves to prolong the local effect and limit systemic absorption. Administration protocols require aspiration prior to injection to ensure proper placement and prevent unintended vascular delivery. Pediatric dosing for the anesthetic application is calculated by weight, not to exceed 15 mg/kg for 0.5% solutions.

When used in the Procaine Penicillin G combination, the administration route is strictly restricted to deep intramuscular (IM) injection only and must never be administered intravenously. Dosing for adults typically falls within the range of 600,000 to 1,000,000 units of the Penicillin G component per administration. The frequency for many infections is typically once daily (qDay), with treatment defined by a fixed course duration, such as 10 days for streptococcal infections. Procedural instructions for the combination product mandate that the injection be administered at a slow, steady rate and that the site be varied for repeated doses.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies

Overview of Study Scope and Findings

Studies have evaluated the effects of the drug on pain scores in patients with moderate-to-severe chronic pain. Studies have also explored the drug's relationship with the body's opioid receptor system.

  • Dose-Response Trials: Several studies investigated the outcomes of administering the combination in the context of chronic and acute pain over a 12-week period. Research explored different dosages to establish the exposure range associated with the most frequently reported changes in pain perception.
  • Key Phase III Trial (RCT): One key study reported findings regarding the measured change in pain scores over time, as measured by the Visual Analog Scale (VAS) score. The primary endpoint was the mean change in VAS from baseline at Week 8. The study included a comparison group receiving a standard-of-care pain reliever, with research exploring its performance in the context of a comparison group.

Studies on Pharmacokinetics and Absorption

Research focused on the drug's absorption rate, distribution, metabolism, and excretion in healthy adult volunteers. Studies evaluated outcomes when the drug was administered with food, and examined whether this affected absorption.

  • Observed Timing: Research evaluated the timing of reported changes in pain scores, with results indicating measurement changes within the initial hour of administration in an open-label trial.
  • Metabolism: The active component is processed mainly by the liver. Studies identified the primary metabolites and explored their contribution to the drug's overall profile.

Safety and Participant Research

Safety research included Phase I, II, and III trials. The most frequently reported adverse events included gastrointestinal disturbances, headache, and drowsiness.

  • Specific Populations: Another study described the general reception of the drug among participants; however, research on patients with liver impairment is limited.
  • Dosing: Research did not evaluate outcomes in participants who exceeded the maximum studied dose.
  • Inflammation Response: Research evaluated inflammation-related endpoints, with study results compared to Placebo in a 4-week trial.
  • Participant Feedback: Studies investigated reported analgesic properties and assessed participant feedback through quality-of-life questionnaires.

Key Studies & References

  1. Efficacy and Safety of Procaine Hydrochloride in Chronic Pain Management: A Phase 3 Randomized Controlled Trial
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Procaine hydrochloride (FAQ)

Q: Does procaine hydrochloride interact with other medicines?

Studies and official information indicate that Procaine hydrochloride can interact with certain other medicines, which may affect how well it works or increase the risk of side effects. For example, it may interact with cholinesterase inhibitors or sulfonamides. For this reason, official product information states that it is important to inform a healthcare provider of all other medications being taken before use.

Q: Can I use Procaine hydrochloride if I have kidney or liver problems?

Regulatory documents state that caution is needed when Procaine hydrochloride is administered to individuals with severe kidney (renal) or liver (hepatic) impairment. This is because the body's ability to process and eliminate the medicine can be reduced in these conditions. Official product information states that the use of the medication in these conditions requires a careful assessment of the patient's status by a healthcare professional.

Q: What is Procaine hydrochloride used for?

According to the official product information, Procaine hydrochloride is typically used as a local anesthetic to temporarily numb a specific area of the body. It belongs to the amino ester group of anesthetics. This temporary numbing allows for minor medical procedures to be performed with less pain.

Q: Can Procaine hydrochloride be used for children?

Official information indicates that Procaine hydrochloride can be used in the pediatric population (children). Regulatory sources emphasize that when used in children, the dosage must be determined and managed carefully to ensure the lowest effective amount is used. This is a standard safety measure for use in younger patients.

Q: What happens if I receive too much Procaine hydrochloride?

Receiving too much Procaine hydrochloride is known as an overdose, which can lead to serious side effects. According to regulatory documents, initial symptoms may include central nervous system effects, such as excitement, nervousness, or dizziness. More severe reactions like seizures or loss of consciousness may follow, which requires immediate medical attention.

Q: What is the onset of action for Procaine hydrochloride?

Studies and official information indicate that Procaine hydrochloride has a relatively rapid onset of action, meaning the numbing effect begins quickly after administration. It is also characterized by a short duration of action. This makes it suitable for minor procedures where a brief period of local anesthesia is needed.

Advertisements

How should Procaine hydrochloride be stored and disposed of?

How to Store and Dispose of Procaine Hydrochloride

Procaine hydrochloride must be stored according to strict regulatory guidelines to maintain its stability and ensure safety.

Official Storage and Handling

The product must be stored at room temperature, typically between +15°C and +25°C, in a dry, well-ventilated place. It is classified as air and light sensitive, requiring the container to be kept tightly closed and protected from direct sunlight. For safety, a mandatory requirement is to store locked up or only in areas accessible to qualified or authorized persons.

Disposal Requirements

Disposal must follow pharmaceutical waste protocols. The product cannot be disposed together with household garbage and must not be allowed to enter drains or water systems. Disposal requires taking the contents and container to an approved waste disposal plant or a special waste collection point in accordance with all local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Procaine hydrochloride found in:

A-Z Index: